Pulmonary Disease Doctors in Palos Heights, IL Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Arpana Paruchuri, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-4529

Dr. Marvi Bikak, M.D Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13303 S Ridgeland Ave Unit C, Palos Heights, IL 60463 Phone: 815-941-2007

Bassam Hashem, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-3388    Fax: 708-923-3380

Dr. Terrence C Moisan, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 12255 S 80th Ave, Palos Heights, IL 60463 Phone: 708-448-1400

Dr. Michael W Heniff, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11824 Southwest Hwy, Suite 130, Palos Heights, IL 60463 Phone: 708-277-6150    Fax: 708-277-6110

News Archive

New pricing of $19,500 set for Illumina's individual genome sequencing service

Illumina, Inc. today announced a new price of $19,500 for its individual genome sequencing service. In addition, the company announced a price of $14,500 per genome for groups of five or more participants using the same physician. Individuals with serious medical conditions for whom whole-genome sequencing could provide potential direct clinical value will be eligible for special pricing of $9,500 per genome.

HRSA's Wakefield talks about ACOs and community health centers

Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.

Study: One in five adults experienced a decrease in their sexual behavior early in the pandemic

One in five adults in the United States report they have experienced change - mostly a decrease - in their sexual behavior during the early months of the COVID-19 pandemic, according to a new study by Indiana University researchers.

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.

Study shows link between animal's diet during sexual development and breeding habits

An animal's choice of mate can be influenced by its diet as it reaches sexual maturity, research has shown.

Read more Medical News

› Verified 6 days ago